624 Longitudinal scRNAseq profiling of PBMCs from melanoma patients treated with anti-CTLA4 or anti-PD1/CTLA4 combination elucidates mechanisms of immunotherapy resistance

Схожие документы

• The impact of dropouts in scRNAseq dense neighborhood analysis
  по: Alisa Pavel, и др.
  Опубликовано: (2025-01-01)
• scRNAseq, bulk-RNAseq and Future Deep Learning RNAseq Analysis: Powerful Prediction Tools in Prostate Cancer Therapy
  по: Mohammad Hosein Karimi
  Опубликовано: (2024-09-01)
• Discovering Heterogeneous Leukocytes Subsets Associated With Alcoholic Steatohepatitis by scRNAseq Analysis
  по: Haribalan Perumalsamy, и др.
  Опубликовано: (2025-11-01)
• Insights Gained and Future Outlook From scRNAseq Studies in Autoimmune Rheumatic Diseases
  по: Zihan Zheng, и др.
  Опубликовано: (2022-02-01)
• Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells.
  по: Raven M Osborn, и др.
  Опубликовано: (2023-01-01)